Search
SOLACI Congress
HomeFilePeripheral vascular disease

Peripheral vascular disease

View Category

Antithrombotic Anticoagulants

ESC 2020 | Rivaroxaban Might Reduce Cardiac Cerebral and Peripheral Events

Adding rivaroxaban to the standard treatment might reduce events incidence in lower limbs, heart, and brain, in...
solaci -
Learn More
Femoral

SOLACI PERIPHERAL | 3rd Clinical Case: Femoral PCI

In keeping with its Clinical Case Discussion Program, SOLACI’s peripheral interventions department, SOLACI Peripheral, presents the third...
solaci -
Learn More
Aorta

SOLACI Peripheral Webinar | Update in Thoracic and Thoracoabdominal Aortic Aneurysms

Watch again our Webinar on "Update in Thoracic and Thoracoabdominal Aortic Aneurysms” on our Youtube account.  We are...
solaci -
Learn More
Carotid

Natural History of Severe and Asymptomatic Carotid Lesions

Deciding whether to intervene a severe (70-80%) carotid lesion in an asymptomatic patient is challenging. We know...
solaci -
Learn More
Aorta

Webinar SOLACI Peripheral | Update on Thoracic and Thoracoabdominal Aortic Aneurysms

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...
solaci -
Learn More
Acute coronary syndromes

Infarction, Stroke and Aortic Emergency Syndromes in the Shadow of the Pandemic

The coronavirus pandemic has had a negative impact on the most pressing cardio and neurological emergencies, such...
solaci -
Learn More
Coronary disease

Rapid Drop of Antibodies in Mild COVID-19 patients

A fast drop in COVID-19 antibodies in mild patients triggers the alarm for protection against the new...
solaci -
Learn More
Other

COVID-19 PE: Nontraditional Risk Factors?

Risk factors for pulmonary embolism (PE) among patients with the new coronavirus are different from those traditionally...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy